Your session is about to expire
← Back to Search
Camostat for Coronavirus
Study Summary
This trial is designed to find new COVID-19 treatments that work for people who are infected but not yet sick enough to require hospitalization. The trial will test different therapies and adapt as new information becomes available.
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 2 & 3 trial • 4044 Patients • NCT04518410Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals have signed up to participate in this research project?
"This study is not actively recruiting patients at this time. The study was initially posted on 4/23/2021 and was most recently edited on 9/12/2022. If you are searching for for other studies, there are currently 1137 studies actively searching for participants with covid19 and 4 studies for Camostat actively searching for participants."
Are individuals over the age of 50 eligible to participate in this research project?
"Eligibility requirements for this study include being over 18 but under 80 years old."
Has Camostat gone through the FDA's approval process?
"Camostat's safety was given a score of 2 out of 3 because, while there is data supporting its safety, Phase 2 trials have not yet yielded any efficacy data."
Is this a new clinical trial?
"Currently, 4 clinical trials are running that involve Camostat. These studies span 11 countries and 177 cities. The first study began in 2020 and was sponsored by AstraZeneca. This initial trial had 4044 participants and completed Phase 2 & 3 of drug approval process. In the year since then, 12 more studies have been conducted."
How can I sign-up for this opportunity?
"Eligible patients for this study must have contracted covid19 and be between 18-80 years old. So far, the trial has enrolled 122 individuals."
Are we still able to register for this trial?
"This particular trial is not currently recruiting patients. However, it's important to note that the date of the last update was September 12th, 2022. There are 1137 other trials related to Covid-19 that are actively searching for participants and 4 trials for Camostat."
What is the published research on Camostat's efficacy?
"Out of the 4 ongoing studies involving Camostat, 1 is currently in Phase 3. Most research surrounding Camostat takes place in Miami, yet there are 260 different clinical trial sites worldwide."
Share this study with friends
Copy Link
Messenger